HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Surgery in (pre)malignant celiac disease.

AbstractAIM:
To report the outcome of surgery in patients with (pre)malignant conditions of celiac disease (CD) and the impact on survival.
METHODS:
A total of 40 patients with (pre)malignant conditions of CD, ulcerative jejunitis (n = 5) and enteropathy associated T-cell lymphoma (EATL) (n = 35), who underwent surgery between 2002 and 2013 were retrospectively evaluated. Data on indications, operative procedure, post-operative morbidity and mortality, adjuvant therapy and overall survival (OS) were collected. Eleven patients with EATL who underwent chemotherapy without resection were included as a control group for survival analysis. Patients were followed-up every three months during the first year and at 6-mo intervals thereafter.
RESULTS:
Mean age at resection was 62 years. The majority of patients (63%) underwent elective laparotomy. Functional stenosis (n = 13) and perforation (n = 12) were the major indications for surgery. In 70% of patients radical resection was performed. Early postoperative complications, mainly due to leakage or sepsis, occurred in 14/40 (35%) of patients. Eight patients required reoperation. More patients who underwent resection in the acute setting (n = 3, 20%) died compared to patients treated in the elective setting. With a median follow-up of 20 mo, seven patients (18%) required reoperation due to long-term complications. Significantly more patients who underwent acute surgery could not be treated with adjuvant chemotherapy. Patients who first underwent surgical resection showed significantly better OS than patients who received chemotherapy without resection.
CONCLUSION:
Although the complication rate is high, the preferred first step of treatment in (pre)malignant CD consists of local resection as early as possible to improve survival.
AuthorsJolanda M W van de Water, Petula Nijeboer, Laura R de Baaij, Jessy Zegers, Gerd Bouma, Otto J Visser, Donald L van der Peet, Chris J J Mulder, Wilhelmus J H J Meijerink
JournalWorld journal of gastroenterology (World J Gastroenterol) Vol. 21 Issue 43 Pg. 12403-9 (Nov 21 2015) ISSN: 2219-2840 [Electronic] United States
PMID26604647 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Antineoplastic Agents
Topics
  • Aged
  • Antineoplastic Agents (therapeutic use)
  • Celiac Disease (diagnosis, drug therapy, mortality, surgery)
  • Chemotherapy, Adjuvant
  • Digestive System Surgical Procedures (adverse effects, mortality)
  • Elective Surgical Procedures
  • Enteropathy-Associated T-Cell Lymphoma (diagnosis, drug therapy, mortality, surgery)
  • Female
  • Humans
  • Intestinal Neoplasms (diagnosis, drug therapy, mortality, surgery)
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Netherlands
  • Postoperative Complications (etiology)
  • Precancerous Conditions (diagnosis, drug therapy, mortality, surgery)
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: